Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy

ClinicalTrials.gov ID: NCT01602120

Public ClinicalTrials.gov record NCT01602120. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 11:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Lampalizumab (FCFD4514S) in Patients With Geographic Atrophy Who Have Completed Genentech-Sponsored Lampalizumab Studies

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, open-label extension study of safety and tolerability of lampalizumab administered by intravitreal (ITV) injection to participants with geographic atrophy (GA) who have completed the 18-month treatment in Study CFD4870g (GX01456) (NCT01229215) or 24-week treatment in Study GX29455 (NCT02288559).

Study identification

NCT ID
NCT01602120
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genentech, Inc.
Industry
Enrollment
159 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
60 Years to 89 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 29, 2012 (Actual)
Primary completion
Nov 8, 2017 (Actual)
Completion
Feb 9, 2018 (Actual)
Last update posted
Sep 11, 2019

2012 – 2018

United States locations

U.S. sites
41
U.S. states
23
U.S. cities
40
Facility City State ZIP Site status
Retina Centers P.C. Tucson Arizona 85704 —
Retina-Vitreous Assoc Med Grp Beverly Hills California 90211 —
Retinal Diagnostic Center Campbell California 95008 —
The Retina Partners Encino California 91436 —
Loma Linda University Loma Linda California 92354 —
San Diego Retina Associates Oceanside California 92056 —
W Coast Retina Med Group Inc San Francisco California 94107 —
West Coast Retina San Francisco California 94107 —
California Retina Consultants Santa Barbara California 93103 —
Retina Macula Institute Torrance California 90503 —
Colorado Retina Associates, PC Golden Colorado 80401 —
Retina Group of Florida Boca Raton Florida 33431 —
National Ophthalmic Research Institute Fort Myers Florida 33912 —
Florida Eye Associates Melbourne Florida 32901 —
Retina Care Specialists Palm Beach Gardens Florida 33410 —
Retina Specialty Institute Pensacola Florida 32503 —
Ctr for Retina & Macular Dis Winter Haven Florida 33880 —
Southeast Retina Center Augusta Georgia 30909 —
Wolfe Eye Clinic West Des Moines Iowa 50266 —
Elman Retina Group Baltimore Maryland 21237 —
Ophthalmic Consultants of Boston Boston Massachusetts 02114 —
Vitreoretinal Surgery Edina Minnesota 55435 —
The Retina Institute St Louis Missouri 63128 —
Sierra Eye Associates Reno Nevada 89502 —
Eye Associates of New Mexico Albuquerque New Mexico 87102 —
Opthalmic Consultants of LI Lynbrook New York 11563 —
Western Carolina Retinal Associate PA Asheville North Carolina 28803 —
Char Eye Ear &Throat Assoc Charlotte North Carolina 28210 —
Retina Assoc of Cleveland Inc Beachwood Ohio 44122 —
Cincinnati Eye Institute Cincinnati Ohio 45242 —
Dean McGee Eye Institute Oklahoma City Oklahoma 73099 —
Retina Northwest Portland Oregon 97221 —
Mid Atlantic Retina Philadelphia Pennsylvania 19107 —
Charleston Neuroscience Institute Ladson South Carolina 29456 —
Southeastern Retina Associates Knoxville Tennessee 37923 —
Tennessee Retina PC Nashville Tennessee 37203 —
W Texas Retina Consultants PA Abilene Texas 79606 —
Retina Research Center Austin Texas 78705 —
Texas Retina Associates Dallas Texas 75231 —
Wagner Macula & Retina Center Norfolk Virginia 23451 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01602120, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 11, 2019 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01602120 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →